Bioqual Inc
OTC:BIOQ

Watchlist Manager
Bioqual Inc Logo
Bioqual Inc
OTC:BIOQ
Watchlist
Price: 38.5 USD Market Closed
Market Cap: $34.3m

Operating Margin

-4.8%
Current
Declining
by 4.2%
vs 3-y average of -0.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4.8%
=
Operating Income
$-1.8m
/
Revenue
$37.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-4.8%
=
Operating Income
$-1.8m
/
Revenue
$37.2m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Bioqual Inc
OTC:BIOQ
34.4m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.9B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...

Market Distribution

In line with most companies in the United States of America
Percentile
30th
Based on 14 112 companies
30th percentile
-4.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Bioqual Inc
Glance View

Market Cap
34.3m USD
Industry
Biotechnology

Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The firm also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. The In vitro services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays. The firm provides its services to the federal government, universities and the life science and pharmaceutical industries.

BIOQ Intrinsic Value
40.3 USD
Undervaluation 4%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-4.8%
=
Operating Income
$-1.8m
/
Revenue
$37.2m
What is Bioqual Inc's current Operating Margin?

The current Operating Margin for Bioqual Inc is -4.8%, which is below its 3-year median of -0.5%.

How has Operating Margin changed over time?

Over the last 3 years, Bioqual Inc’s Operating Margin has decreased from 11.5% to -4.8%. During this period, it reached a low of -7% on Nov 30, 2024 and a high of 11.5% on Jan 28, 2022.

Back to Top